Rapid Diagnostics Companies

Top Industry Leaders in the Rapid Diagnostics Market

Rapid Diagnostics Key Companies

Latest Rapid Diagnostics Companies Update:

Abbott Laboratories Launched the Panbio™ COVID-19 Ag Rapid Test Device Self-Test, expanding access to convenient and reliable at-home COVID-19 testing.

Becton, Dickinson and Company (BD) Collaborated with the Bill & Melinda Gates Foundation to develop and distribute Veridi™, a rapid, low-cost test for HIV that can be easily performed in resource-limited settings.

Roche Diagnostics Received FDA approval for the Elecsys BRAF V600 Mutation Test, the first rapid point-of-care test for identifying melanoma-causing BRAF mutations, enabling swift treatment decisions.

LumiraDx Launched the LumiraDx SARS-CoV-2 & Influenza A/B Test, a multiplex test capable of simultaneously detecting these common respiratory viruses in minutes, improving diagnostic efficiency.

QuidelOrtho Announced the development of a rapid antigen test for Group A streptococcal pharyngitis, aiming to reduce unnecessary antibiotic use and improve patient care.

List of Rapid Diagnostics Key companies in the market

Abaxis

Becton

Dickinson & Company

Bio-Rad Laboratories

Accriva Diagnostics

ACON Laboratories Inc

Hologic Inc

Abbott Laboratories

Roche Diagnostics

Bayer HealthCare Pharmaceuticals LLC

Cepheid Inc

Rapid diagnostics companies specialize in the development and production of quick and efficient diagnostic tests that provide results in a short period. These tests are often used for point-of-care or near-patient testing to enable rapid decision-making in healthcare settings.

Top Industry Leaders in the Rapid Diagnostics Market